Treatment of anxiety and gastrointestinal disorders with azabicy

Details Treatment of anxiety and gastrointestinal disorders with azabicy Treatment of anxiety and gastrointestinal disorders with azabicy

1993-08-13

1995-07-25

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514214, 514215, 546124, A61K 3144

Patent

active

054362512

ABSTRACT:
(Endo)-N-[[[8-azabicyclo[3.2.1]octan-3-yl]amino]carbonyl]-2-(cyclopropylmet hyloxy)benzamide and pharmaceutically acceptable salts thereof possess 5-HT.sub.3 antagonistic activity and are useful in the treatment of neuro-psychiatric disorders (e.g. anxiety), gastro-intestinal disorders and migraine.

REFERENCES:
patent: 4983600 (1991-01-01), Ward et al.

Affiliated with

Also associated with

Rating

Treatment of anxiety and gastrointestinal disorders with azabicy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of anxiety and gastrointestinal disorders with azabicy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of anxiety and gastrointestinal disorders with azabicy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-739800